Latest / Now Innovating / Now Innovating: Training the Body to Prevent Stroke and Beyond
Transcript
- 0:14Welcome to Now Innovating,
- 0:15a Research-to-Impact series
- 0:16at the University of Calgary.
- 0:18I'm your host, Julia MacGregor.
- 0:20In this episode, I speak with Dr. Aravind Ganesh,
- 0:23a vascular and cognitive neurologist
- 0:24at the University of Calgary.
- 0:26His clinical research focuses
- 0:28on the prevention and treatment of stroke
- 0:29and cognitive impairment.
- 0:31He is actively developing innovations
- 0:33to diagnose and prevent stroke,
- 0:34as well as serving as CEO of Let's Get Proof,
- 0:37a platform to advance research
- 0:38collaboration and engagement.
- 0:42Hello Aravind, and welcome to Now Innovating.
- 0:44Thank you.
- 0:44Really happy to have you on the show.
- 0:45I’ve been wanting to chat with you for a while
- 0:47since I took over this series.
- 0:49To give our audience context, you’re a neurologist,
- 0:51and I'm hoping that you can first
- 0:52tell us about really the correlation between,
- 0:53you know, stroke and dementia
- 0:55and why continued research and innovation
- 0:56is really necessary in this area.
- 0:58So stroke is one of the leading
- 1:00causes of death and disability worldwide,
- 1:03and it is also, unfortunately,
- 1:05one of the leading causes of dementia.
- 1:07And several of the risk factors
- 1:09for stroke and dementia
- 1:10shared their what we call
- 1:11vascular risk factors.
- 1:13And there are certain conditions
- 1:14that dramatically increase
- 1:16the risk of both stroke
- 1:18and dementia simultaneously.
- 1:20One of those conditions
- 1:21that we're really interested in
- 1:22studying in the lab is called
- 1:23cerebral small vessel disease.
- 1:25And that's a condition that's often
- 1:28caused by hypertension,
- 1:30high blood pressure,
- 1:31but also by conditions that overlap
- 1:35with Alzheimer's disease.
- 1:36And so as our understanding
- 1:38of both stroke and dementia grows,
- 1:40we find that there is
- 1:42actually a lot of interconnections
- 1:43between these two conditions.
- 1:45And as I went through my training
- 1:46as a neurologist,
- 1:47I became quite fascinated by
- 1:50the potential opportunity that exists
- 1:52to uncover insights about both of
- 1:55these conditions and drive improvements
- 1:57in care for these conditions.
- 1:58And so I thought that was
- 1:59a fascinating opportunity.
- 2:01And that's what's inspired and sustained my lab
- 2:04over the last few years.
- 2:05So I'm really excited to learn
- 2:07more about some of the innovations
- 2:08that you know, you're working on to help,
- 2:09you know, diagnose and prevent stroke
- 2:11that are in development.
- 2:12Could you tell us about
- 2:13I know one is a RIC device.
- 2:15So this principle of kind of
- 2:18a prior exposure to a loss of blood flow,
- 2:21then allowing an organ to become better
- 2:24at withstanding
- 2:25kind of a massive loss of blood flow.
- 2:27That is the principle that underlies
- 2:29ischemic conditioning. Right.
- 2:31And then what ended up being discovered
- 2:33was that this same benefit,
- 2:35or a very similar benefit,
- 2:36could be acquired
- 2:37by having that prior loss of blood flow
- 2:41happen in an organ or part of the body
- 2:45that's completely far away
- 2:47or remote from the organ
- 2:49that we're trying to protect.
- 2:50And that's what we mean by remote ischemic
- 2:52conditioning and remote ischemic conditioning...
- 2:54We're essentially trying to interrupt
- 2:57blood flow temporarily
- 2:58and repeatedly in a part of the body
- 3:00where it's quite safe to do so.
- 3:02So not something heavy duty
- 3:03like the heart or the brain, but instead
- 3:06trying to do it in somewhere
- 3:07like an arm where, you know,
- 3:08applying a tourniquet
- 3:09might be quite feasible, or leg.
- 3:11My motivation for thinking about RIC
- 3:14actually came from Eric Smith, my mentor
- 3:17and now close colleague,
- 3:19and Eric shared with me
- 3:20the literature around RIC,
- 3:23and he had become
- 3:24quite interested in that topic.
- 3:26And that interest
- 3:27rubbed off on me as well.
- 3:28And we started thinking about ways
- 3:30in which we could leverage this concept
- 3:32to try and help patients
- 3:33with stroke and dementia.
- 3:35Specifically, we thought that patients
- 3:37with small vessel disease,
- 3:39which, as I mentioned before, is a major
- 3:42cause of both dementias and strokes,
- 3:44would be an interesting place to start.
- 3:47And this was largely
- 3:48because there continued
- 3:50to be no specifically approved therapies
- 3:53to reduce the progression
- 3:55of small vessel disease.
- 3:56So it's an area of great unmet need.
- 3:58So we were thinking, you know,
- 3:59can we create a new version of this device,
- 4:03a new system, that essentially could be tailored
- 4:06to deliver any sort of blood
- 4:09pressure cuff based therapy?
- 4:12And at the same time would overcome
- 4:14this problem of being able to
- 4:15monitor patients effectively
- 4:17and of course, being able to offer
- 4:19meaningful technical support.
- 4:20And so this was where the idea
- 4:22for the recovery device was born.
- 4:24And this was back in 2019, 2020
- 4:28that I started working with a few students
- 4:35from the engineering department
- 4:37and also from the health sciences department
- 4:39through the Neuro Nexus kind of hackathon
- 4:43that had happened for the first time
- 4:45around that period.
- 4:47And so we essentially
- 4:49went in pitching this idea to students
- 4:52first and saying, hey, would you like to
- 4:54work with us on thinking
- 4:55about how we might tackle this?
- 4:56And so we had a very initial kind of
- 4:58barebones version of this
- 5:00that we put together
- 5:01through that competition,
- 5:02which convinced us that, you know what,
- 5:04we could actually make our own device
- 5:06right here in Calgary,
- 5:07potentially that can overcome
- 5:09some of these challenges.
- 5:10And so that was a very exciting
- 5:11moment for me.
- 5:13I had never really thought of going
- 5:16into sort of a device making kind of journey.
- 5:19But you know, it was kind of
- 5:22born out of necessity and curiosity.
- 5:24And then, fast forward a few years.
- 5:29I had developed the idea enough
- 5:32that we had filed a patent around it.
- 5:34We had obtained some initial
- 5:39seed funding from Campus Alberta Neuroscience.
- 5:42So again, a big connection to the UofC there,
- 5:45to further build some initial prototypes.
- 5:49We then, were able to get support
- 5:54from Brain Canada,
- 5:56from the Canadian Stroke Consortium,
- 5:58from the Alzheimer's Society of Alberta
- 6:02and the Northwest Territories,
- 6:03all of which helped us advance this
- 6:06device along its development journey.
- 6:09In collaboration with
- 6:11a Calgary based device engineering company
- 6:14called FUEL Biomedical.
- 6:16And at this point now in 2026,
- 6:20we have a version of the device
- 6:24that has received Health Canada approval for
- 6:28investigational testing in clinical trials.
- 6:31My name is Kaden - I'm a MD/PhD student
- 6:34here at the University of Calgary.
- 6:35I’m supervised by Dr. Aravind Ganesh,
- 6:38and here I have the recovery device
- 6:40for RIC, or
- 6:42Remote Ischemic Conditioning therapy.
- 6:44So essentially it's just this modified
- 6:46blood pressure cuff.
- 6:47Just take it off like normal
- 6:49a blood pressure cuff.
- 6:50Slip it on one of your arms.
- 6:55Make sure it gets all snug.
- 6:57And then once you're ready
- 6:58and you’re all settled down,
- 6:59you'll hold the start button here
- 7:01and it'll start inflating.
- 7:04It does that for about five minutes.
- 7:05So, you can see his colour’s
- 7:06started changing. He’s started to become
- 7:08a little bit purple there, because it's
- 7:10the blood is just pooling down there.
- 7:12And then it will stay that way
- 7:13for about five minutes
- 7:14and then it'll deflate
- 7:15and then you'll see the colour rush back
- 7:17The way the therapy works, and the
- 7:19part of the reason we do
- 7:20this is so people can tolerate it well,
- 7:22is he gets five minutes of treatment
- 7:24and then he gets five minutes of relief.
- 7:26It can mimic the effects of exercise.
- 7:28So reduce oxygen flow
- 7:30throughout your body.
- 7:31And then in terms of what it does
- 7:33for stroke prevention and dementia,
- 7:35it can improve blood flow and strengthen
- 7:37the blood vessels as well.
- 7:39But on top of that, it also improves
- 7:41your brain's ability to protect itself.
- 7:43So it strengthens the blood brain barrier
- 7:46so it prevents things from going into the brain
- 7:48and things leaking out of the brain.
- 7:50You can do this in a safe way
- 7:53to repeatedly subject the body to
- 7:56the sort of like ischemia or decreased blood flow
- 7:59and have stuff released that's then helpful.
- 8:03There's also neuronal pathways
- 8:06that happen that are beneficial
- 8:08then for the central nervous system,
- 8:09because there's feedback
- 8:11that travels back to the brain
- 8:12and the spinal cord that then,
- 8:14you know, start to have protective pathways
- 8:17that will reduce cell death.
- 8:20For in this particular case,
- 8:21it's a total of six cycles.
- 8:22So he’ll get five additional cycles on and off.
- 8:25And then that's basically
- 8:26one therapy session complete.
- 8:34It’s also being used in M.S. trials?
- 8:35So what are the other... yeah.
- 8:36That's right. So, well, you know, once I started
- 8:41down this remote ischemic conditioning journey,
- 8:45a really important collaborator
- 8:47and partner and friend that I made along
- 8:49the way was Dr. Carlos Camara-Lemarroy.
- 8:52He's an M.S. neurologist in Calgary who also runs
- 8:59a basic sciences lab, an animal lab,
- 9:01where he's able to test out
- 9:03animal models of different conditions.
- 9:05And he had become very interested
- 9:07in remote ischemic conditioning
- 9:10as a potential neuroprotective strategy
- 9:13in cases of M.S. - particularly in cases
- 9:16of progressive multiple sclerosis.
- 9:18Even if you manage to control the
- 9:21the inflammatory component of the disease,
- 9:23which is what most existing treatments target.
- 9:26And so Dr. Carlos Camara-Lemarroy.
- 9:30became interested in was seeing
- 9:34if the patients that were in very much
- 9:36a progressive course of illness,
- 9:38if this treatment strategy, the RIC
- 9:42treatment strategy, might help
- 9:44prevent that progression of disease
- 9:46by virtue of protecting the neurons
- 9:49through protective pathways
- 9:51that are activated by this treatment.
- 9:55And so one ongoing trial,
- 9:58now clinical trial that's led by him
- 9:59in human patients with M.S.
- 10:02- its primary progressive M.S.
- 10:04is a trial where patients are going to be
- 10:07using our device for a year.
- 10:10And we're going to try and see if
- 10:13their rates of progression are better
- 10:16than what is expected.
- 10:18Really, that's been a really rewarding
- 10:20and fruitful collaboration for us
- 10:22because in addition to Carlos and his team
- 10:25using our devices in their study,
- 10:27Carlos has also played a very,
- 10:29very important role in studying
- 10:31the changes in blood biomarkers
- 10:33that are happening to patients
- 10:34over the course of treatment with RIC,
- 10:38and seeing how that compares to
- 10:40what happens to mice
- 10:41when they are treated
- 10:42with this treatment strategy
- 10:44over similar periods of time.
- 10:46So then this allows us to try and figure out
- 10:48sort of a shared and common pathways
- 10:52by which this device might be,
- 10:54and this treatment strategy
- 10:56might be making a difference
- 10:57to these neurological conditions.
- 10:59So that's been a really rewarding and interesting
- 11:02part of this scientific journey.
- 11:04One of the things that we're really proud of,
- 11:06Carlos and myself, is that through this years
- 11:08long collaboration, we've essentially
- 11:10had this kind of bench to bedside and back
- 11:14kind of approach to thinking about
- 11:18this, this innovation and scientific journey.
- 11:20And I that's that's something that can feed
- 11:25and promote a lot of meaningful
- 11:27research and development in the future.
- 11:29That's very cool. And so from
- 11:32like at the side of the treatment therapy
- 11:33side, you're also doing innovations looking at
- 11:35automated neuroimaging analysis.
- 11:37Can you tell us about that quickly?
- 11:39Sure. So, you know,
- 11:40central to the diagnosis of
- 11:43of both stroke and dementia
- 11:45these days is the use of neuroimaging scans,
- 11:48CT scans and MRI scans.
- 11:50So, you know, when we think
- 11:52about the person hours that go into detailed
- 11:56analysis and characterization of this,
- 11:57it's staggering in our lab.
- 12:01And then when you think from a,
- 12:03from an international standpoint,
- 12:04you know, the the millions of human hours
- 12:06that go into this. So between 2016 and 2023,
- 12:09around 40,000 people in Alberta
- 12:12had strokes in TIA’s.
- 12:13Right now, that is a massive, massive number.
- 12:18There's opportunity there though
- 12:20because or from the routinely obtained
- 12:24imaging data and clinical data
- 12:25for these patients,
- 12:26we can obtain a great deal of insights
- 12:28about their risk factors for stroke, things
- 12:31that put people at risk for recurrent strokes
- 12:33coming back again and again with strokes, right,
- 12:36and potentially inform new treatment
- 12:39strategies, new clinical trials,
- 12:41new risk stratification approaches.
- 12:42We started an innovation journey
- 12:44to try and finesse our ability to detect
- 12:48and quantify each of these features
- 12:51so that we could then apply them
- 12:53in essentially a batch processing
- 12:55kind of way, and analyze hundreds
- 12:58to thousands of scans at a time
- 13:00over the course of days,
- 13:02as opposed to over the course of years.
- 13:04Julia: That's very cool. I love that.
- 13:06I was curious too, because, like,
- 13:07I know with the RIC device and I think
- 13:10through some of your other work to,
- 13:11like through PENTOS-AI
- 13:13and another where you've been
- 13:14in health pitch competitions.
- 13:15That’s right, yeah.
- 13:17So including the Hopewell M.I.N.D. Prize
- 13:19and W21C Innovation Academy.
- 13:20And I'm just curious,
- 13:21could you speak to the benefit,
- 13:22you know, that you've had competing
- 13:24in these types of things.
- 13:25Over the years when we've returned to,
- 13:28to such innovation events,
- 13:31whether it is through things like Neuro Nexus,
- 13:33whether it's through the Spark
- 13:35entrepreneurship program at the UofC,
- 13:39these have now been experiences
- 13:40where I've been able
- 13:41to bring my students along, right.
- 13:43So in all of these later initiatives and also
- 13:48now in pursuing things
- 13:49like the Mind Prize locally,
- 13:51which also involves pitch competitions,
- 13:52these have been opportunities for me
- 13:54to bring my trainees into the limelight,
- 13:57give them an opportunity to,
- 13:59kind of hone a different set of skills
- 14:02and conventional,
- 14:03you know, research skills
- 14:04or writing skills, let's say.
- 14:06And to me, both personally
- 14:10and as a mentor, it's been great to see
- 14:13how participating in this has improved
- 14:15my own communication skills and importantly,
- 14:17the confidence and skills of my trainees. Right.
- 14:20So we learn to try and synthesize
- 14:26our ideas into language
- 14:29that makes sense to people
- 14:30that are non-experts.
- 14:32It gives us a way to try
- 14:35and become better at storytelling,
- 14:37which is a critical way in which
- 14:39all humans communicate. Right?
- 14:41And very, very importantly, just like these,
- 14:45how these bench to bedside
- 14:46collaborations end up
- 14:47benefiting both these funds,
- 14:49this sort of entrepreneurial
- 14:51and research collaborations do end up
- 14:54benefitting the research world as well,
- 14:56because we take those skills back and
- 15:00apply them in our own research
- 15:02and writing pursuits to become better
- 15:04at those too. Because, as it turns out,
- 15:07even when you're communicating
- 15:08to a scientific audience,
- 15:10guess what? Stories resonate with them.
- 15:12Going through a startup
- 15:14or entrepreneurial venture,
- 15:15you know it teaches you how to
- 15:16pull yourself up by your bootstraps and,
- 15:19you know, manage your finances wisely
- 15:21and and budget wisely
- 15:22and all those kinds of things, too.
- 15:24You're also currently CEO of Let's Get Proof.
- 15:26And I think that kind of
- 15:27touches on about, you know,
- 15:28you need financial support
- 15:29to continue research and stuff like that.
- 15:31And my understanding is Let’s Get Proof
- 15:32is a platform dedicated to improving
- 15:34medical research collaboration,
- 15:35public engagement and translation.
- 15:37Could you tell us more about like, yeah,
- 15:39like why this platform is needed
- 15:40and maybe impacts you've seen through it?
- 15:42Totally, so you know, going through the
- 15:46research and innovation journey, one can't help
- 15:51but think about different processes
- 15:53as well as obstacles
- 15:55that people have to overcome
- 15:57to try and get their ideas funded,
- 15:59to try and get their ideas,
- 16:04executed in the form
- 16:05of meaningful studies
- 16:06and then taken through the publication
- 16:08and real world impact. Right.
- 16:09So you you can't help
- 16:10but think about how that life cycle
- 16:13looks, not just in our own lab,
- 16:15but also across, labs around the world.
- 16:18And one of the things that I found myself
- 16:22very interested in understanding was how
- 16:27research projects get funded
- 16:29and what sort of ideas
- 16:31might be unintentionally left behind. Right.
- 16:34And so I became interested
- 16:35in sort of inequities in medical research
- 16:39funding and design and execution.
- 16:41And as the pandemic happened and progressed,
- 16:47we also saw what can happen
- 16:49when scientific research pursuits
- 16:53are unable to communicate their,
- 16:57you know, reality and their truth
- 16:59to the general public. Right,
- 17:01because the pandemic was actually,
- 17:03frankly, a time of incredible
- 17:05scientific achievement.
- 17:06Right? There was a virus
- 17:08that we hadn't heard about.
- 17:09And building on years of prior research,
- 17:13we were able to get
- 17:15highly effective vaccines to people
- 17:17we were able to figure out
- 17:18through multiple clinical trials
- 17:19You know what the best treatment course is.
- 17:23But at the same time,
- 17:24you pick an average person off the street
- 17:26and ask them about what
- 17:27their perception was of research
- 17:29and science related to the pandemic.
- 17:31You'll hear a lot of misinformation, right?
- 17:33You'll hear a lot of mistrust.
- 17:35It made me wonder,
- 17:36can we do a better job of translating our
- 17:39our research knowledge?
- 17:41Can we do a better job of engaging patients
- 17:44in the public in this pursuit?
- 17:46And this is and, you know like many other things,
- 17:49as I was thinking through this, other close
- 17:51colleagues of mine
- 17:52were thinking through this too.
- 17:53And one of them was Dr. Mayank Goyal
- 17:55another person who's gone from mentor
- 17:57to friend and close colleague.
- 17:59And together we co-founded
- 18:03Let's Get Proof with some other
- 18:04like minded folks.
- 18:05And we also created a website where
- 18:10anyone with an interest in a
- 18:12particular scientific
- 18:13topic could create, like working groups,
- 18:15where they could bring together
- 18:17like-minded individuals to work on
- 18:19kind of potentially niche projects,
- 18:21but projects that deserved
- 18:22attention and interest, the focus of the
- 18:25of the company in recent years
- 18:27actually moved away from crowdfunding
- 18:29and moved more towards
- 18:30the empowering collaboration,
- 18:32knowledge translation, medical education.
- 18:35And so that's a way in
- 18:36which our own journey has evolved over time.
- 18:38Again, it's been interesting
- 18:39to bring students along in this journey,
- 18:41because students in the lab now
- 18:42find it actually fascinating to take
- 18:44ideas and papers that we're working
- 18:46on, try and write about them in lay language,
- 18:49and post them as part of the knowledge
- 18:51translation, public engagement
- 18:52content on the website. Right.
- 18:54And people that are
- 18:56coming into medical research
- 18:58without a clinical background
- 19:00find it helpful to use the working groups
- 19:02to try and find like minded patients
- 19:04and clinicians that they can
- 19:06then bring along
- 19:06for their research innovation journey.
- 19:08So I want to end with,
- 19:09because you've talked a lot
- 19:11about like collaborating with your other,
- 19:12like, mentors and other researchers
- 19:14and bringing students
- 19:14into that piece and, you know,
- 19:16working with external companies
- 19:17to develop device hardware.
- 19:18I was hoping you could just talk
- 19:19about the necessity of this and like,
- 19:22when is the right time
- 19:23to find partners for your research
- 19:25and your innovation journey?
- 19:27So, for example, you know,
- 19:28maybe the world...
- 19:29it was not the right time to,
- 19:30to do crowdfunding in research, right.
- 19:32Maybe right? And was it really the right time
- 19:36for me as a new researcher,
- 19:41to be trying to make a medical device?
- 19:43Tough to know, right?
- 19:44I certainly know, I'm sure that if we had
- 19:49tried and use an astrological lens to this,
- 19:53you know, to try and figure is the timing, right.
- 19:55You know, we would have stalled
- 19:56and we wouldn't have done stuff.
- 19:57I am more driven by the question of,
- 20:02you know, where is the science pointing me,
- 20:05and where do I see necessity?
- 20:08That is what I have found
- 20:10personally more helpful
- 20:11than thinking about is the timing, right?
- 20:13But that's a personal thing for me.
- 20:15And I feel, you know, if there are
- 20:21trainees or students or early career researchers
- 20:24that have a certain passion or curiosity
- 20:28or a necessity that they've seen
- 20:29that's burning within them,
- 20:31I would say act now because
- 20:34who knows what what will happen
- 20:36in a few years from now.
- 20:37That’s amazing.
- 20:38Thank you so much, Aravind, for joining us
- 20:39and telling us all about your experience,
- 20:40and I look forward
- 20:41to seeing the impacts of the RIC device
- 20:43as it goes through clinical trials.
- 20:44Thank you.
- 20:46You can
- 20:47find links in our
- 20:47episode description to learn
- 20:48more about Let's Get Proof,
- 20:50as well as the research
- 20:50that the Hotchkiss Brain Institute
- 20:52in the Cumming School of Medicine
- 20:53is doing to promote healthy brain
- 20:54aging, including cognitive disorders,
- 20:57dementia, and stroke.
- 20:58And for more information
- 20:59on how to move your research-to-impact
- 21:00in the UCalgary Innovation Ecosystem,
- 21:03visit ucalgary.ca/innovation